שמור ב:
| מחבר ראשי: | |
|---|---|
| פורמט: | Recurso digital |
| שפה: | |
| יצא לאור: |
Zenodo
2025
|
| גישה מקוונת: | https://doi.org/10.5281/zenodo.14990793 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
תוכן הענינים:
- <p>Metastasis is the major cause of death from cancer and metastasis to the lung in breast cancer is difficult to treat and heterogeneous in nature, complicating its management (1-5). We recently utilized whole transcriptome technologies to define the full complement of differentially expressed kinases and phosphatases in HER2+ breast cancer: in the primary tumor, and in metastasis to the CNS (6-8). Here we utilize whole transcriptome technologies (9, 10) to measure total transcription in the lung metastases of humans with breast cancer. We identify here a therapeutic target based on its differential expression and up-regulation upon metastasis to the lung in humans with breast cancer, PFKFB4, as a candidate therapeutic target for the medical management of lung metastasis. </p>